InvestorsHub Logo
Followers 151
Posts 86857
Boards Moderated 1
Alias Born 11/29/2003

Re: CABRALEES post# 99249

Tuesday, 04/10/2007 10:42:44 AM

Tuesday, April 10, 2007 10:42:44 AM

Post# of 376163
dunno on DNDN, CAB...but Adam Fueststein came up with a valuation model for Provenge...you might want to read this old article...fwiw

http://www.thestreet.com/newsanalysis/pharmaceuticals/10345925.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.